In this study, we confirmed that the aberrant overexpression of SLCO4A1-AS1 is associated with poor prognosis in multiple CRC cohorts and revealed that promoter hypomethylation is a key mechanism mediating the upregulation of SLCO4A1-AS1 in CRC. The gene discussed is SLCO4A1; the disease is colorectal carcinoma.